why choose us

First received: February 28, 2023

Clinical Trial: Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Plaque Psoriasis

Study Type: INTERVENTIONAL


Official Title: Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Padagis' Roflumilast Cream 0.3% to Arcutis's Zoryve™ (Roflumilast Cream 0.3%) Cream and Both Activ

Brief Summary: To compare the safety and efficacy of Padagis' product to an FDA approved product for the treatment of plaque psoriasis

Read more